08.30-09.30 | | AOR 4: Cutting-edge imaging technologies for the aorta
Chair: Nick Cheshire, Natzi Sakalihasan |
 | Athanasios Katsargyris | Use of Fusion imaging in fenestrated and branched EVAR - does it work? |
| Jonathan Nadjiri | Perspectives of Magnetic Resonance Imaging (MRI) for aortic aneurysms and dissections |
| Michael Rasper | What Spectral CT Angiography could add in the (follow-up) diagnostics of aortic diseases |
| Jean Paul de Vries | Apposition software to calculate apposition of endografts in the aortic neck – prediction of EVAR failures during follow-up |
| Marc Bailey | Molecular imaging of cell proliferation in pre-clinical abdominal aortic aneurysm |
| | |
09.30-10.45 | | AOR 5: Novel concepts and insights from translational aortic aneurysm research
Chair: Philip Tsao, Lars Maegdefessel |
| Ronald Dalman | Keynote Lecture: Pathophysiological impact of diabetes on AAA disease |
| Per Eriksson | Molecular and cellular mechanisms of thoracic aortic aneurysms |
| Natzi Sakalihasan | Cancer and AAA: a causal role for chronic inflammation? |
| Martin Björck | Physical activity and the risk to develop AAA |
| Anders Wanhainen | Ticagrelor and the inhibition of growth in small AAAs – results from a RCT |
| Clark Zeebregts | Skin accumulation of advanced glycation endproducts is increased in AAA patients |
| | |
11.10-12.30 | | AOR 6: Chronic aortic dissections and thoraco-abdominal aortic aneurysms – technical issues and long-term outcomes
Chair: Tina Cohnert, Piotr Kasprzak, Friedhelm Beyersdorf |
| Clark Zeebregts | Perioperative mortality, paraplegia, stroke and long-term stent related complications after TEVAR for traumatic thoracic aortic lesions |
| Anders Wanhainen | A dissection-specific stent graft to prevent distal Stent-graft induced New Entry (dSINE) |
| Martin Czerny | Mechanisms of and treatment strategies for dSINE after TEVAR for acute and chronic type B aortic dissection- Insights from EuREC |
| Tilo Kölbel | False lumen embolisation: devices and techniques |
| Nabil Chakfé | Are all thoracic endografts the same? |
| Colin Bicknell | The compliance with “best” medical therapy in type B aortic dissection patients is poor – we need to optimize medical treatments to improve long-term outcomes |
| Athanasios Katsargyris | Update on long-term durability of fenestrated and branched endografts for Thoraco-Abdominal Aortic Aneurysms (TAAA) |
| | |
13.30-15.10 | | AOR 7: Abdominal aortic aneurysms (AAA) – genetics, guidelines and outcomes after open and endovascular repair
Chair: Anders Wanhainen, Jes Lindholt |
| Philip Tsao | Keynote lecture: Genetics of AAA – what clinicians need to know in 2017 |
| Ron Dalman | Update on the 2017 AAA management guidelines of the Society of Vascular Surgery (SVS) |
| Frank Vermassen | The 5.5 cm/5 cm threshold is completely arbitrary, some AAAs rupture at smaller diameters |
| Bijan Modarai | Determinants of survival after EVAR - an analysis of >700 endovascular aortic procedures to determine 5-year survival |
| Ian Loftus | EVAR and open repair show equivalent outcomes in younger patients - predicting long-term outcomes |
| Thomas Schmitz-Rixen | A real-world based score to assess the procedural risk of EVAR and OR for non-ruptured AAA – data from the aortic registry of the German Vascular Society (DGG) |
| Athanasios Giannoukas | Mid- and long-term renal function outcomes after elective EVAR vs. OR: do we really know enough on which treatment is superior |
| Hubert Schelzig | Centralising therapy of non-ruptured and ruptured AAA – update of the facts |
| | |
15.40-16.40 | | AOR 8: Endoleaks type I and III – still an unresolved issue in endovascular repair of juxtarenal AAA and TAAA
chair: Ron Dalman, Hubert Schelzig |
| Stephan Haulon | How I plan and perform fenestrated aortic endografting and how I flare the viscero-renal grafts to prevent type III endoleaks |
| Ralf Kolvenbach | Routine closure of gutters with liquid polymer solves the chimney problem and makes them as good as fenestrated grafts |
| Afshin Assadian | Viscero-renal stentgraft for chimneys, FEVAR and BEVAR – which one is better or are they all the same? |
| Pjotr Kasprzak | Patient selection in hostile necks and how to prevent endoleaks – a word of caution |
| Ian Loftus | The role of parallel grafts and endovascular aortic sealing (EVAS) - do they fill a gap? |
| Jürgen Falkensammer | Benchside testing for patient safety: assessment of pull-out forces before complex EVAR |
| | |
16.10-17.55 | | CAR 7/PAD 8/AOR 9: Radiation protection and team training 2017
Chair: Moritz Wildgruber, NN |
| Bijan Modarai | Keynote lecture: Determinants of occupational radiation exposure and current practice of radiation protection in the Hybrid OR |
| Houman Jalaie | Radiation exposure during venous stenting |
| Klaus Mathias | Key points in radiation protection in the angio lab – experiences and advices from an endovascular pioneer |
| Heiko Wendorff | ITIX: Influence of an intensive radiation-protection-Training on the Intraoperative X-ray-radiation exposure in a hybrid OR |
| Jan Brunkwall | Is the Vessel Navigator of any benefit for the patient? - results from a comparison of (T)EVAR with and without |
| Tina Cohnert | Hybrid OR with an installed „Zero Gravity“ radiation protection system |
| Lars Lönn | Assessment of competence in EVAR procedures – A novel rating scale using Delphi technique |
| Colin Bicknell | Generation of high performance teams in emergency aortic surgery: Simulated leadership and team training is effective in improving the outcomes and safety of procedures |
| Johannes Gahlen | How to build up and train an endovascular team of doctors, nurses and technicians – a particular challenge for Hybrid ORs |
| | |
16.45-18.15 | | CAR 8: Short communications III: Carotid stenosis (CAR)
Chair: Richard Bulbulia, Kornelia Kreiser, Daniel Staub |
| Alexandr Korotkikh* | Carotid endarterectomy and carotid stenting in patients with atrial fibrillation with using Dabigatran Etexilate |
| Peter Konstantiniuk* | Smoking is a significant risk-factor for postoperative cerebral events in CABG and simultaneous internal carotid endarterectomy |
| Amedeo Carmignani* | Clinical and cytological correlation in the vulnerable atherosclerostic carotid plaque: monocentric experience |
| Grigorios Voulalas* | Smooth muscle cells‘ level of MMP-9 and TIMP-1 could potentially indicate plaque instability |
| Iryna Shevchenko* | Case of successful combined treatment of giant paraganglioma of neck |
| Didem Melis Oztas* | How to clamp and revascularize the brain if the patient has only single vessel blood supply that contains severe stenosis? |
| Armelle Meershoek* | CEA for patients with a recurrent symptomatic internal carotid artery near occlusion with full collapse: report of 17 cases |
| Ian David van Koeverden* | Repeated carotid endarterectomy: Do plaques change over time? |
| Konstantinos Spanos* | A long-term observational study of carotid artery treatment |
| Alexander Zimmermann | Perioperative platelet inhibition is a MUST - data from the German Carotid Registry on 117,973 procedures |
| Michael Kallmayer | Transcarotid Artery Stenting (T-CAR) with flow reversal – our experience with this innovative tool to treat carotid stenoses |
| Vanessa Pourier* | Innervation of extracranial carotid aneurysms and popliteal aneurysms |
| Christoph Schäffer | The assessment of carotid stenoses by contrast-enhanced tomographic ultrasound |
| Andreas Kühnl | Significant association between the neurological status on admission and the in-hospital risk of stroke or death after CEA and CAS |
| | |
| | |
